Ani Pharmaceuticals reported $287.16M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Abbvie ABBV:US $ 73474M 3210M
Aerie Pharmaceuticals AERI:US $ 311.68M 77.15M
Ani Pharmaceuticals ANIP:US $ 287.16M 0.21M
Aurora Cannabis Inc ACB:CN 388.14M 26.31M
Canopy Growth Corp WEED:CN C$ 1.5B 152.36M
Depomed DEPO:US $ 73.52M 0.03M
Eli Lilly And LLY:US $ 16508.8M 375.9M
Emergent Biosolutions EBS:US $ 833.1M 7.9M
Endo International Ordinary Shares ENDP:US $ 8090.62M 183.92M
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Hikma Pharmaceutical HIK:LN 846M 86M
Knight Therapeutics Inc GUD:CN C$ 46.79M 5.83M
Lannett LCI:US $ 610.08M 6.6M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 31275M 250M
Omeros OMER:US $ 313.9M 517K
Perrigo Ordinary Shares PRGO:US $ 3515.2M 5.3M
Teva Pharmaceutical TEVA:IT 22.92B 126M
Teva Pharmaceutical Industries TEVA:US $ 22917M 126M